<DOC>
	<DOCNO>NCT00014950</DOCNO>
	<brief_summary>Although cystic fibrosis ( CF ) common , life-threatening autosomal recessive genetic disorder white population , often delay diagnosis hence start treatment . Advances past two decade make CF screen feasible use routinely collect neonatal blood specimen measure enzyme level follow CF mutation DNA analysis . Our overall goal study see early diagnosis CF neonatal screen medically beneficial without major risk . ''Medically beneficial '' refers well nutrition and/or pulmonary status , whereas `` risk '' include laboratory error , miscommunication misunderstanding , adverse psychosocial consequence . Specific aim include assessment benefit , risk , cost , quality life , cognitive function associate CF neonatal screening well understand epidemiology CF . A comprehensive , randomized clinical trial emphasize early diagnosis key variable underway since 1985 . Nutritional status assess use height weight measurement biochemical method . The result demonstrate significant benefit screen ( early diagnosis ) group . We focus effect early diagnosis CF pulmonary outcome . Pulmonary status measure use chest radiograph , chest scan use high resolution computerize tomography , pulmonary function test . Other factor look include risk factor acquisition respiratory pathogen Pseudomonas aeruginosa , quality life cognitive function child CF undergo early versus delay diagnosis , well cost effectiveness screen cost diagnosis treatment CF throughout childhood . If question underlie study answer favorably , likely neonatal screen use combination enzyme level ( immunoreactive trypsinogen ) DNA test become routine method identify new case CF State Wisconsin , throughout country .</brief_summary>
	<brief_title>Benefits Risks Newborn Screening Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<criteria>Must bear State Wisconsin Must bear April 15 , 1985 June 30 , 1994 Must valid newborn screen test cystic fibrosis first 28 day life . Must sweat chloride test great equal 60 mmol/Liter Parental consent</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Immunoreactive trypsinogen</keyword>
	<keyword>deltaF508- CFTR gene</keyword>
	<keyword>newborn screening</keyword>
	<keyword>Pseudomonas aeruginosa infection</keyword>
	<keyword>nutrition</keyword>
	<keyword>pulmonary status</keyword>
	<keyword>meconium ileus</keyword>
	<keyword>growth</keyword>
	<keyword>Genetic counseling</keyword>
	<keyword>risk communication</keyword>
</DOC>